# Maitreyi Raman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/maitreyi-raman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 5,902 |
| Field | Inflammatory Bowel Disease |
| h-index | 37 |
| i10-index | 76 |
| Last Known Institution | University of Calgary |
| OpenAlex ID | https://openalex.org/A5005105120 |
| ORCID iD | 0000-0002-9129-3632 |
| Works | 214 |

## Researcher papers

- [Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease](https://scholariq.org/papers/fecal-microbiome-and-volatile-organic-compound-metabolome-in-obese-humans-with/)
- [Topical tofacitinib for atopic dermatitis: a phase <scp>II</scp> a randomized trial](https://scholariq.org/papers/topical-tofacitinib-for-atopic-dermatitis-a-phase-scp-ii-scp-a-randomized-trial/)
- [Prevalence and Mechanisms of Malnutrition in Patients With Advanced Liver Disease, and Nutrition Management Strategies](https://scholariq.org/papers/prevalence-and-mechanisms-of-malnutrition-in-patients-with-advanced-liver/)
- [A practical approach to nutritional screening and assessment in cirrhosis](https://scholariq.org/papers/a-practical-approach-to-nutritional-screening-and-assessment-in-cirrhosis/)
- [A randomized phase 2b trial of baricitinib, an oral Janus kinase (<scp>JAK</scp>) 1/JAK2 inhibitor, in patients with moderate‐to‐severe psoriasis](https://scholariq.org/papers/a-randomized-phase-2b-trial-of-baricitinib-an-oral-janus-kinase-scp-jak-scp-1/)
- [Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study](https://scholariq.org/papers/nutritional-assessment-and-hepatic-fatty-acid-composition-in-non-alcoholic-fatty/)
- [The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistance](https://scholariq.org/papers/the-potential-role-of-prebiotic-fibre-for-treatment-and-management-of-non/)
- [Prevalence and Risk Factors for Fatigue in Adults With Inflammatory Bowel Disease: A Systematic Review With Meta-Analysis](https://scholariq.org/papers/prevalence-and-risk-factors-for-fatigue-in-adults-with-inflammatory-bowel/)
- [Parenteral Nutrition and Lipids](https://scholariq.org/papers/parenteral-nutrition-and-lipids/)
- [Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial](https://scholariq.org/papers/histological-improvement-of-non-alcoholic-steatohepatitis-with-a-prebiotic-a/)
- [S1351 Clinical Outcomes of Adult Patients With Short Bowel Syndrome Treated With Teduglutide: A 2-year Cohort Study From the Canadian Home Parenteral Nutrition Registry](https://scholariq.org/papers/s1351-clinical-outcomes-of-adult-patients-with-short-bowel-syndrome-treated-with/)
- [Longer-term effectiveness and safety of teduglutide in adults with short bowel syndrome in Canada using real-world evidence](https://scholariq.org/papers/longer-term-effectiveness-and-safety-of-teduglutide-in-adults-with-short-bowel/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Nutrition and Health in Aging](https://scholariq.org/topics/nutrition-and-health-in-aging/)
- [Clinical Nutrition and Gastroenterology](https://scholariq.org/topics/clinical-nutrition-and-gastroenterology/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)

## Researcher university

- [University of Calgary](https://scholariq.org/institutions/university-of-calgary/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.